Evaluation of Anti-HIF and Anti-Angiogenic Properties of Honokiol for the Treatment of Ocular Neovascular Diseases

Open Access

Peer-reviewed

Research Article

Divya Teja Vavilala,

Affiliation Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri, United States of America
⨯
V. K. Chaithanya Ponnaluri,

Affiliation Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri, United States of America
⨯
Debolina Kanjilal,

Affiliation Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri, United States of America
⨯
Mridul Mukherji

* E-mail: mukherjim@umkc.edu

Affiliation Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri, United States of America
⨯

Reader Comments (0)

Hypoxia
Is the Subject Area "Hypoxia" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Medical hypoxia
Is the Subject Area "Medical hypoxia" applicable to this article?

Thanks for your feedback.
Angiogenesis
Is the Subject Area "Angiogenesis" applicable to this article?

Thanks for your feedback.
Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.
Ocular tumors
Is the Subject Area "Ocular tumors" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Vasculogenesis
Is the Subject Area "Vasculogenesis" applicable to this article?

Thanks for your feedback.